logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Richard D. Baird

Cancer Research UK Cambridge Centre
H指数:41
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ctDNA predicts radiological response to immune checkpoint inhibition for patients with advanced oesophageal adenocarcinoma: a pilot interventional phase 2 study

循环肿瘤DNA预测免疫检查点抑制剂对晚期食管腺癌患者的影像学反应：一项干预性II期初步研究

Communications Medicine
IF6.3
2026-08-120
OA
Constanza Linossi; Alexander A. Azizi; Andrea Machin; Alimu Dayimu; Nikos Demiris; Helen White; Ahmad Miremadi; Maria O’Donovan; Edmund Godfrey; Paulius D. Mennea; Ze Zhou; Angela An; Richard D. Baird; Elizabeth Smyth; Iris Faull; Simon J. Dovedi; Rebecca C. Fitzgerald; Amit Roshan; Simon Pacey
SERENA-6 visual patient-reported outcomes and safety: camizestrant for emerging ESR1m advanced breast cancer during first-line endocrine-based therapy

SERENA-6视觉患者报告结局与安全性：卡米昔司rant用于新发ESR1m晚期乳腺癌的一线内分泌治疗

Oncologist
IF4.2
2026-07-240
OAAI
Adam Brufsky, MD; Yeon Hee Park, MD; François-Clément Bidard, MD; Erica L Mayer, MD; Wolfgang Janni, MD; Cynthia Ma, MD; Massimo Cristofanilli, MD; Giampaolo Bianchini, MD; Hiroji Iwata, MD; Peter A Fasching, MD; Zbigniew Nowecki, MD; Javier Pascual, MD; Shin-Cheh Chen, MD; Lionel Moreau, MD; Manuel Ruiz-Borrego, MD; Ayelet Shai, MD; Nuri Karadurmus, MD; Kyung Hae Jung, MD; Yuichiro Kikawa, MD; Richard D Baird, MD; Ranya Habash, MD; Rebecca Sugarman, MSc; Steven Fox, MSc; Manuel Selvi Miralles, MD; Cynthia Huang Bartlett, MD; Nicholas Turner, MD; null
Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial

评估孕激素受体激动剂甲地孕酮联合来曲唑治疗早期雌激素受体阳性乳腺癌的妇女: 机会之窗，随机，2b期，PIONEER试验

Nature Cancer
IF28.5
2026-01-050
OAAI
Rebecca A. Burrell; Sanjeev Kumar; Elena Provenzano; Cleopatra Pike; Alimu Dayimu; Stuart A. McIntosh; Vassilis Pitsinis; Polly King; Beatrix Elsberger; Sasi Govindarajulu; Lucy Satherley; Sirwan Hadad; Peter Schmid; Amit Agrawal; Bodiere Akpuluma; Steven Bell; John R. Benson; Carlos Caldas; Danya Cheeseman; Igor Chernukhin; Parto Forouhi; Tulay Gulsen; Eleftheria Kleidi; Karen Pinilla; Wendi Qian; Jean E. Abraham; Jason S. Carroll; Richard D. Baird
Collaborative framework on responsible AI in LLM-driven CDSS for precision oncology leveraging real-world patient data

基于真实世界患者数据的LLM驱动型CDSS在精准肿瘤学中负责AI的协作框架

npj Precision Oncology
IF8
2025-12-040
OAAI
Sonja Mathes; Dyke Ferber; Tobias Dreyer; Kai J. Borm; Luise Modersohn; Theresa Willem; Richard Dirven; Julien Vibert; Simon Kreutzfeldt; Raquel Perez-Lopez; Arsela Prelaj; Fredrik Strand; Richard D. Baird; Martin Boeker; Jakob Nikolas Kather; Maximilian Tschochohei; Jacqueline Lammert
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment

CDK4/CDK6抑制剂在激素受体阳性乳腺癌治疗中的敏感性和耐药机制

DRUG RESISTANCE UPDATES
IF21.7
2024-09-014
OAAI
Glaviano, Antonino; Wander, Seth A.; Baird, Richard D.; Yap, Kenneth C. -H.; Lam, Hiu Yan; Toi, Masakazu; Carbone, Daniela; Geoerger, Birgit; Serra, Violeta; Jones, Robert H.; Ngeow, Joanne; Toska, Eneda; Stebbing, Justin; Crasta, Karen; Finn, Richard S.; Diana, Patrizia; Vuina, Karla; de Bruin, Robertus A. M.; Surana, Uttam; Bardia, Aditya; Kumar, Alan Prem
A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results

在ER阳性，HER2-negative晚期乳腺癌女性中，下一代口服SERD camizestrant的I期剂量递增和扩展试验: SERENA-1单药治疗结果

ANNALS OF ONCOLOGY
IF65.4
2024-08-016
OAAI
Hamilton, E.; Oliveira, M.; Turner, N.; Garcia-Corbacho, J.; Hernando, C.; Ciruelos, E. M.; Kabos, P.; Ruiz-Borrego, M.; Armstrong, A.; Patel, M. R.; Vaklavas, C.; Twelves, C.; Boni, V.; Incorvati, J.; Brier, T.; Gibbons, L.; Klinowska, T.; Lindemann, J. P. O.; Morrow, C. J.; Sykes, A.; Baird, R. D.
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally
CANCER DISCOVERY
IF33.3
2024-07-010
PRE
Carmona, Javier; Chavarria, Elena; Donoghue, Kate; von Gertten, Christina; Oberrauch, Petra; Pailler, Emma; Scoazec, Giovanni; Weijer, Ruud; Balmana, Judith; Brana, Irene; Brunelli, Cinzia; Delaloge, Suzette; Deloger, Marc; Delpy, Pierre; Ernberg, Ingemar; Fitzgerald, Rebecca C.; Garralda, Elena; Lablans, Martin; Lehtio, Janne; Lopez, Carlos; Fernandez, Maialen; Miceli, Rosalba; Nuciforo, Paolo; Perez-Lopez, Raquel; Provenzano, Elena; Schmidt, Marjanka K.; Serrano, Cesar; Steeghs, Neeltje; Tamborero, David; Wirta, Valtteri; Baird, Richard D.; Barker, Karen; Barlesi, Fabrice; Baumann, Michael; Bergh, Jonas; de Braud, Filippo; Fizazi, Karim; Frohling, Stefan; Piris-Gimenez, Alejandro; Seamon, Kenneth; van der Heijden, Michiel S.; Zwart, Wilbert; Tabernero, Josep
Results of the window-of-opportunity PIONEER trial evaluating addition of the progesterone receptor (PR) agonist megestrol to letrozole for early stage estrogen receptor (ER) positive breast cancer: exploiting ER-PR interaction
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Burrell, Rebecca; Kumar, Sanjeev; McIntosh, Stuart; Pitsinis, Vassilis; King, Polly; Elsberger, Beatrix; Govindarajulu, Sasirekha; Satherley, Lucy; Hadad, Sirwan; Schmid, Peter; Abraham, Jean; Agrawal, Amit; Benson, John; Cheeseman, Danya; Chernukhin, Igor; Forouhi, Parto; Kleidi, Eleftheria; Pike, Cleopatra; Pinilla, Karen; Provenzano, Elena; Qian, Wendi; Carroll, Jason; Baird, Richard
SERENA-1: Results from a Phase 1 study (Parts I/J) testing the next-generation oral selective estrogen receptor degrader (SERD) camizestrant (AZD9833) in combination with capivasertib in women with ER+, HER2 advanced breast cancer

SERENA-1: 1期研究 (I/J部分) 的结果，该研究测试了ER，HER2晚期乳腺癌女性的下一代口服选择性雌激素受体降解剂 (SERD) camizestrant (AZD9833) 与capivasertib的组合

CANCER RESEARCH
IF16.6
2024-05-021
PRE
Vaklavas, Christos; Oliveira, Mafalda; Armstrong, Anne; Moreno, Irene; Twelves, Chris; Ruiz, Ivan Victoria; Bermejo, Begona; Ajimi, Maxine; Brier, Tim; Ciardullo, Carmela; Gibbons, Lisa; Irurzun-Arana, Itziar; Jack, Tony; Klinowska, Teresa; Lindemann, Justin; Mathewson, Alastair; Morrow, Christopher; Sykes, Andy; Baird, Richard
The prognostic and predictive impact of circulating tumour DNA (ctDNA) dynamics in patients with metastatic Triple Negative Breast Cancer (TNBC) on olaparib based therapy: Results from Cohort E of the PlasmaMATCH trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Browne, Iseult; Pascual, Javier; Cutts, Rosalind; Kingston, Belinda; Hrebien, Sarah; Kilburn, Lucy; Pearson, Alex; Moretti, Laura; Wardley, Andrew; Macpherson, Iain; Baird, Richard; Roylance, Rebecca; Faull, Iris; Banks, Kimberly C.; Garcia-Murillas, Isaac; Bliss, Judith; Ring, Alistair; Turner, Nicholas
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)
CLINICAL CANCER RESEARCH
IF10.2
2023-09-294
OAAI
Ring, Alistair; Kilburn, Lucy S.; Pearson, Alex; Moretti, Laura; Afshari-Mehr, Angelica; Wardley, Andrew M.; Gurel, Bora; Macpherson, Iain R.; Riisnaes, Ruth; Baird, Richard D.; Martin, Sue; Roylance, Rebecca; Johnson, Hannah; Ferreira, Ana; Winter, Matthew C.; Dunne, Kathryn; Copson, Ellen; Hickish, Tamas; Burcombe, Russell; Randle, Kat; Serra, Violeta; Llop-Guevara, Alba; Bliss, Judith M.; Turner, Nicolas C.
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

PI3K/AKT/mTOR信号转导通路与肿瘤靶向治疗

MOLECULAR CANCER
IF33.9
2023-08-18376
OAAI
Glaviano, Antonino; Foo, Aaron S. C.; Lam, Hiu Y.; Yap, Kenneth C. H.; Jacot, William; Jones, Robert H.; Eng, Huiyan; Nair, Madhumathy G.; Makvandi, Pooyan; Geoerger, Birgit; Kulke, Matthew H.; Baird, Richard D.; Prabhu, Jyothi S.; Carbone, Daniela; Pecoraro, Camilla; Teh, Daniel B. L.; Sethi, Gautam; Cavalieri, Vincenzo; Lin, Kevin H.; Javidi-Sharifi, Nathalie R.; Toska, Eneda; Davids, Matthew S.; Brown, Jennifer R.; Diana, Patrizia; Stebbing, Justin; Fruman, David A.; Kumar, Alan P.
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib (vol 14, 4444, 2023)
NATURE COMMUNICATIONS
IF15.7
2023-08-070
OAAI
Coombes, R. C.; Howell, Sacha; Lord, Simon R.; Kenny, Laura; Mansi, Janine; Mitri, Zahi; Palmieri, Carlo; Chap, Linnea I.; Richards, Paul; Gradishar, William; Sardesai, Sagar; Melear, Jason; O'Shaughnessy, Joyce; Ward, Patrick; Chalasani, Pavani; Arkenau, Tobias; Baird, Richard D.; Jeselsohn, Rinath; Ali, Simak; Clack, Glen; Bahl, Ashwani; McIntosh, Stuart; Krebs, Matthew G.
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
NATURE COMMUNICATIONS
IF15.7
2023-07-2418
OAAI
Coombes, R. Charles; Howell, Sacha; Lord, Simon R.; Kenny, Laura; Mansi, Janine; Mitri, Zahi; Palmieri, Carlo; Chap, Linnea I.; Richards, Paul; Gradishar, William; Sardesai, Sagar; Melear, Jason; O'Shaughnessy, Joyce; Ward, Patrick; Chalasani, Pavani; Arkenau, Tobias; Baird, Richard D.; Jeselsohn, Rinath; Ali, Simak; Clack, Glen; Bahl, Ashwani; McIntosh, Stuart; Krebs, Matthew G.
A highly sensitive and specific PARylation assay confirms significant and durable target engagement by AZD5305 in patients
CANCER RESEARCH
IF16.6
2023-04-140
OA
Lombardi, Benedetta; Marco-Casanova, Paola; Karapetsas, Athanasios; Hornett, Mya; Lukacs, Edit; Sugibayashi, Ko; Cosulich, Sabina; Dowson, Adam; Moorthy, Ganesh; Brown, Jessica; Yap, Timothy A.; Schram, Alison M.; Balmana, Judith; Luen, Stephen J.; Im, Seock-Ah; Sharp, Adam; Baird, Richard; Harrington, Elizabeth A.; Linardopoulos, Spiros
The next generation oral selective estrogen receptor degrader (SERD) camizestrant (AZD9833) is active against wild type and mutant estrogen receptor α
CANCER RESEARCH
IF16.6
2023-03-012
OA
Morrow, Christopher; Carnevalli, Larissa; Baird, Richard D.; Brier, Tim; Ciardullo, Carmela; Cureton, Natalie; Lawson, Mandy; McEwen, Robert; Nikolaou, Myria; Armstrong, Anne; Bermejo, Begona; Calvo, Emiliano; Ciruelos, Eva; Garcia-Corbacho, Javier; Hamilton, Erika; Incorvati, Jason; Kabos, Peter; Oliveira, Mafalda; Patel, Manish R.; Ruiz-Borrego, Manuel; Turner, Nicholas; Twelves, Chris; Vaklavas, Christos; Carroll, Danielle; Ching, Steven; Cvetesic, Nevena; DuPont, Michelle; Gibbons, Lisa; Mathewson, Alastair; Maudsley, Rhiannon; Gutierrez, Pablo Morentin; Reddy, Avinash; Rodriguez-Canales, Jaime; Ros, Susana; Sudhan, Dhivya; Sykes, Andy; Whitson, David; Klinowska, Teresa; Lindemann, Justin
SERENA-1: Updated analyses from a Phase 1 study of the next generation oral selective estrogen receptor degrader camizestrant (AZD9833) combined with abemaciclib, in women with ER-positive, HER2-negative advanced breast cancer
CANCER RESEARCH
IF16.6
2023-03-017
OA
Turner, Nicholas; Vaklavas, Christos; Calvo, Emiliano; Garcia-Corbacho, Javier; Incorvati, Jason; Borrego, Manuel Ruiz; Twelves, Chris; Armstrong, Anne; Bermejo, Begona; Hamilton, Erika; Oliveira, Mafalda; Ciruelos, Eva; Kabos, Peter; Patel, Manish R.; Borrell, Maria; Burris, Howard; de Paula, Bruno; Falcon, Alejandro; Hernando, Cristina; Moreno, Irene; O'Brien, Ciara S.; Shagisultanova, Elena; Ruiz, Ivan Victoria; Wang, Judy S.; Wei, Mei; Brier, Tim; Carroll, Danielle; Ciardullo, Carmela; Gibbons, Lisa; Irurzun-Arana, Itziar; Jack, Tony; Kirova, Bistra; Klinowska, Teresa; Lindemann, Justin; Maidment, Julie; Mathewson, Alastair; Maudsley, Rhiannon; McEwen, Robert; Morrow, Christopher; Sykes, Andy; Baird, Richard D.

研究方向

暂未获取到该数据
I
Iain R. Macpherson
H 指数:38论文数:295被引数:7,076
N
Nicholas C. Turner
H 指数:92论文数:1,157被引数:4.5万
C
Carlos Caldas
H 指数:158论文数:1,383被引数:12.8万
A
Andrew Wardley
H 指数:53论文数:323被引数:1.9万
R
Rebecca Roylance
H 指数:42论文数:242被引数:9,982
J
Judith M. Bliss
H 指数:90论文数:805被引数:3.8万
L
Lucy Kilburn
H 指数:31论文数:327被引数:7,255
A
Alistair Ring
H 指数:36论文数:307被引数:5,654
J
Javier García-Corbacho
H 指数:18论文数:109被引数:4,777
B
Belinda Kingston
H 指数:9论文数:86被引数:739